R&D + Strategic Partnering
for the Global Vaccine Industry

Dr. Berlanda Scorza is Vice President for Global Health R&D Vaccines and GVGH Institute Director. GVGH is a key component of GSK’s commitment to Global Health, dedicated to developing effective and affordable vaccines for neglected infectious diseases that affect communities in low- and...

Cedric Bogaert cofounded myNEO, whose software uses neural networks trained on biological datasets to figure out the best personalized cancer immunotherapies for a given patient. myNEO focuses on neoantigen targets it identifies from the genomic profile of the tumor sample. Based on promising...

Andrew first studied as a virologist at the University of Warwick before then furthering his education with postgraduate studies in influenza replication at Oxford University. Since then he has applied his scientific knowledge in a commercial setting. After working as part of a multidisciplinary...

Mark A. Emalfarb is the founder of Dyadic. He has been a member of Dyadic's board of directors since October 2004 and has served as its Chairman as well as President and Chief Executive Officer from October 2004 until April 2007 and from June 2008 until the present. Since founding Dyadic in...

Marion Gruber is the Vice President for Public Health and Regulatory  Science at the International AIDS Vaccine Initiative (IAVI).  In this role she is leading the development and execution of IAVI’s public health and regulatory science efforts to advance IAVI’s product development programs in...

Dr. Keirstead is an internationally known stem cell expert and has led therapy development for late stage cancers, immune disorders, motor neuron diseases, spinal cord injury and retinal diseases. He is the CEO of AIVITA Biomedical. He was previously CSO of Caladrius which acquired California Stem...

Jerome H. Kim, M.D., is an international expert on the development and evaluation of vaccines and is the Director General of the International Vaccine Institute (IVI).  He has unparalleled experience and success in translating innovation to impact – working with key national and international...

Geert Leroux-Roels obtained the MD degree from the Ghent University in 1976. He completed a specialty training in internal medicine and conducted doctoral research in clinical pathology and immunology. In 1981 he was board certified in internal medicine and a obtained a PhD degree in biomedical...

Ruben Rizzi, physician by training, SVP of Global Regulatory Affairs at BioNTech. I joined the company in December 2019 just before the pandemic, and I have been the global regulatory lead for BioNTech for our COVID-19 development. Currently, I am still supporting the lifecycle of our COVID-19...

Nigel obtained his BSc in Microbiology and Genetics from University College London (UCL) in 1990 and an MSc in Applied Molecular Biology of Infectious Diseases (1992), PhD in Molecular Parasitology (1999) and DLSHTM (2000) from the London School of Hygiene & Tropical Medicine (LSHTM). After his ...

Dr. Veterinary Medicine, virologist, global networking in human and animal health, vaccines and diagnostics, global disease control, one health, public affairs with EU, WHO, Asian and African authorities and experienced in vaccine translational development.Achievements in brief: Discovery of H1N1...

Dr. Maria Elena Bottazzi is an internationally recognized tropical and emerging disease vaccinologist, global health advocate and cocreator of a patent-free, open science COVID-19 vaccine technology that led to the development of Corbevax in India and IndoVac in Indonesia, and with approximately...

Dr. Christensen was recently appointed as Global Head of R&D for Adjuvant Systems at Croda Pharma after 18 years in adjuvant research at Statens Serum Institut, Denmark. During his career, his research focus has been on pharmaceutical and immunological aspects of vaccine adjuvants and delivery...

Dr. Ed Kelley is the Chief Global Health Officer at ApiJectHe recently left his position as the World Health Organization’s Director of Integrated Health Services, where he helped lead the organization’s COVID-19 response, creating WHO’s first public-private collaboration working directly with the...

Dr. Ofer Levy is principal investigator, staff physician and the Director of the Precision Vaccines Program at Boston Children’s Hospital, Professor of Pediatrics at Harvard Medical School, and Associate Member of the Broad Institute of MIT and Harvard. The Precision Vaccines Program (PVP) is an...

Haiko Pillu obtained a Professional Bachelor’s degree in Pharmaceutical andBiological Technology, and started his career in the Lab for Microbiology,Parasitology and Hygiene at the University of Antwerp. He joined SGS in July2006 to lead a group of freelance Lab Technicians and to develop the...

Walter Straus serves as Vice President, Distinguished Vaccine Safety Scientist, and Dean of Development for Moderna University. Prior to joining Moderna in 2021, for many years he led teams in scientific affairs, epidemiology, and clinical safety and risk management, supporting the vaccine and...

Antonio Garcia Maldonado is an Principal at SIF. He works on international investments with a focus on biotech in Europe and Israel, and tech-enabled service/product delivery in South Asia and Sub-Saharan Africa. Prior to joining the foundation, Antonio worked in the investment banking division at...

Francesco Pappalardo was born in Catania on 11 March 1975. He graduated in Computer Science with 110/110 cum laude on 2000 at the University of Catania; after graduating, in 2004 he obtained the title of Doctor of Philosophy (PhD) in Computer Science. From 2004 to 2011 he was a research fellow at...

Dr. Caldwell is the Associate Vice President, Vaccine Research & Education at Meharry Medical College in Nashville TN. He leads the emerging partnership between Meharry and Clinical Research Associates of Nashville and is a devoted clinician and teacher. Dr. Caldwell serves as an investigator...

Dr Ewer is an expert in the human immune response to vaccination and specialises in understanding how immunity translates into protective efficacy. She undertook her PhD on the immunology of T cell responses to TB and co-developed a diagnostic assay for the early detection of TB infection. She has...

Dr. Lenny Moise, VP Research, manages client projects and scientific development of the SeromYx Systems Serology platform for clinical research and drug discovery in infectious disease, immuno-oncology, autoimmunity and neurology. Prior to joining SeromYx, Lenny was Director of Vaccine Research at...

Dr. Hanna Nohynek (b. 1958) received her MD and PhD degree in the University of Helsinki Finland. She holds special expertise of International Health and Travel Medicine of the Finnish Medical Association. She presently works as Chief Physician in the Department of Health Security in the Finnish...

Ajoy Chakrabarti has over 25 years of diverse product development experience in both pharmaceutical and biotechnology companies. He joined the Gates Foundation in 2016 as the Platform & Portfolio Lead for Polio. The role involves working across multiple polio vaccine programs to provide...

Aaron was born and raised in Bloomfield Hills, MI. He attended the Cranbrook educational community from grades K-12. He traveled west to study chemistry at the California Institute of Technology where he was introduced to boundary-breaking research in the Tirrell lab. After completing his...

Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton University Cancer Sciences. In his postdoctoral work at MIT he developed tools in chemical biology, advanced microscopy and nanotechnology to understand receptor trafficking. He...

Robert Paris is VP, Therapeutic Area Head, Infectious Diseases at Moderna where he leads clinical development for its latent virus portfolio of vaccines include cytomegalovirus, herpes zoster, genital herpes, and Epstein-Barr virus programs as well as Translational Medicine studies. He initially...

A veterinarian by training, after completing my PhD at The Pirbright Institute in 1993 I became Head of the International FMD Vaccine Bank and held the position for 4 years. I moved to Pfizer AH in Sandwich, England in 1997 and eventually became Director of Biologicals Research for Europe, Africa...

Dr. Wolfe currently serve as the Branch Chief for the Vaccine Program in support of the CBRN Division of the Biomedical Advanced Research and Development Authority (BARDA). In doing so, he leads the advanced development and management of complex vaccine projects targeting biological threats. The...

Dr. Costley oversees the strategy and operations for BlueWillow Biologics, a clinical-stage vaccine company that has developed the only intranasal adjuvant platform currently available with established human immunogenicity and safety data. He has held the CEO role at the company since 2021 after...

Ingrid de Visser - Kamerling (1975) graduated in Medical Biology from Leiden University in 1998. She subsequently worked at CHDR as a project leader and PhD student. She obtained her PhD from Leiden University in 2003 and became a registered clinical pharmacologist in 2005. From 2004 to 2007, she...

Professor Anne Moore holds a joint position between the School of Biochemistry and Cell Biology, UCC and the National Institute of Bioprocessing Research and Training (NIBRT). She brings to this joint appointment a wealth of expertise in immunology, bioprocessing, and vaccine development. Professor ...

Roland Zahn is currently Head of Nonclinical and Translational Immunology for Viral Vaccines at Janssen Vaccines and Prevention B.V.. In this role, he leads a team of researchers responsible for all aspects of nonclinical research on viral vaccines, for new vaccines entering the clinical...

James F. Cummings, M.D., FACP, FIDSA, FASTMH  has served as Chief Medical Officer at Vaxart since August 2021 and is responsible for all clinical vaccine development.. Preceding his role at VAXART, Dr. Cummings served as President of ICON Government and Public Health Solutions, Inc., a global...

Professor Petro Terblanche has a successful track record in the strategic and operational management of technology intensive organizations. She has played a key part in the design and implementation of South Africa’s biotechnology strategy. She holds the position of Managing Director of Afrigen...

Dr. Tucker completed his doctoral degree in Immunology at the University of Washington. Dr. Tucker is the Chief Scientific Officer and Vice President for Research at Vaxart, Inc, a company focused on mucosal vaccine delivery. He has published several papers in immunology and served as a grant...

Chris joined Biologics Consulting as a Senior Consultant in 2015 after 2 years as an independent CMC consultant and more than 25 years of experience in the development, manufacturing, and quality control of clinical and commercial biopharmaceutical products, as well as IVDs. Fourteen of those years ...

Dr. Juliana Cassataro leads a research group on Immunology, infectious diseases and vaccine development at the Institute of Biotechnological Research (School of Bio and Nanotechnologies, University of San Martin (UNSAM), IIBIO CONICET), Argentina. Juliana has a degree in Biological Sciences from...

Trang Gisler has over 20 years of scientific/technical, IT and business management experience in both the public and private sector with key emphasis in digital health, clinical trials, vaccine, and program management. She brings with her extensive experience in managing large portfolios for US...

Jenny Joined Crucell, later Janssen Vaccines, in 2006, as a scientist responsible for leading a team that focused on assay development and validation for Adenovirus based vaccines. She led clinical sample analysis and result reporting for vaccines programs such as Malaria, TB, HIV, and EBOLA. ...

Tim Peterson is Scientific Director, Dermal Drug Delivery at Kindeva Drug Delivery’s Woodbury, MN, headquarters. He has been developing and scaling up transdermal and microneedle-enabled drug delivery systems for over 30 years. Prior to Kindeva, Tim led a group focused on the development of new...

Dr Pore is one of the co-founders of Intox Pvt. Ltd and looks over the responsibility of Executive Director and Test Facility Management. Dr Pore is a Diplomate of the American Board of Toxicology (DABT) and also European Registered Toxicologist (ERT) since 2009.   ​Dr Pore has designed and...

Dr. Marco Pravetoni holds the Rick L. Seaver Endowed Professorship in Brain Health, and he is a Professor of Psychiatry and Behavioral Sciences, Professor of Pharmacology, and Director of the Center for Medication Development for Substance Use Disorders and Overdose at the University of Washington...

Melanie Saville, MBBS, is PATH’s Chief Scientific Officer. She leads PATH’s product development division, which includes a global team dedicated to the development, introduction, and scale of vaccines, medical devices, and diagnostics. Dr. Saville is a distinguished physician specializing in...

Dr. Joe Smyser is the CEO of PGP (The Public Good Projects), a public health nonprofit specialized in large-scale media monitoring programs, SBCC programs, and cross-sector initiatives. PGP is a central figure in combating vaccine hesitancy and misinformation. For the past five years, PGP has...

Dr. Uchida is a professor at Tokyo Medical and Dental University and the Chief Medical Officer of Crafton Biotechnology. He leads interdisciplinary research that bridges the fields of medicine and engineering. After graduating from the University of Tokyo Medical School, Dr. Uchida began his career ...

Sebastian Ulbert is a molecular biologist and lecturer in virology. He is the Deputy Director of the Fraunhofer Institute for Cell Therapy and Immunology and the Head of the Department for Vaccines and Infection Models. The Fraunhofer Society is Europe's largest application-oriented research...

Dr Thomas Waite is the Deputy Chief Medical Officer leading on health protection. His role covers emergency response and preparedness, infectious diseases, vaccines and therapeutics. Dr Waite is a consultant epidemiologist and completed his clinical and public health training in south Wales. He is ...

Nico holds a degree Business Engineering and obtained a PhD in Operations Research and Operations Management from KU Leuven in 1996. As full professor at KU Leuven, he is holder of the GSK Research Chairs on Access-to-Medicines, the Janssen Pharmaceutica Research Chair on Pandemic Preparedness and...

Dr. Maya Cabot has been associated with the development of several innovative virology research tools at Integral Molecular. These include Reporter Virus Particles (RVPs) and Influenza TiterSafe™ VLPs, contributing to the advancement of antiviral research and vaccine development. Maya earned her...

Margherita Coccia is a Director for Adjuvant Science and Technology at GSK. She received a M.Sc. in Biotechnology from the University San Raffaele in Milan and a PhD in Immunology from the Dunn School of Pathology at Oxford University. She has more than 10 years of experience in the science of...

Dr. de Jongh has a M.Sc. in Chemical Engineering from the University of Stellenbosch, South Africa and was awarded a doctorate in Biotechnology from the Technical University of Denmark (DTU). Furthermore, he was awarded an affiliated associate professorship at DTU in 2017. Dr. de Jongh has 18 years ...

Dr. Kyle Doolan leads cross-functional teams in molecular biology, protein engineering and virology that perform experiments for operations and research and development. Kyle has been instrumental in enhancing the performance of Integral Molecular’s technologies, and is an inventor on two of the...

As Chief Scientific Officer, Michael is responsible for LimmaTech’s scientific development, focusing on pipeline development and operational R&D performance. Michael has a PhD in Biochemistry from the Swiss Federal Institute of Technology, Zurich (ETH Zurich) and developed a broad experience in ...

Marie-Louise Lunn is Global Product Manager at Novo Nordisk Pharmatech with on enzymes for bioprocessing. She holds a Ph.D. in molecular biology and drug discovery from the University of Copenhagen, Denmark. After working as a postdoctoral researcher at the Salk Institute for Biological Studies in...

Isabel Oliver is the Director General of Science and Research (Chief Scientific Officer) at the UK Health Security Agency (UKHSA). She is a medical epidemiologist who until recently was the Director, National Infection Service of Public Health England leading the specialist epidemiology teams and...

About Dr. Karina Pasquevich: Dr. Karina Pasquevich is an Argentinean scientist with more than 20 years of experience in the field of Immunology. Her journey in this discipline began in 2003, and since then, she has been working in immunology of infectious diseases, vaccine and adjuvant development ...

Mojca Tajnik Sbaizero is Head of Product Application Area at Sartorius BIA Separations, Slovenia. She is a biotechnologist and holds a PhD in Biomedicine-Genetics. Her academic background is in RNA processing and developing novel therapeutic strategies in gene therapy. She is employed in the...

Gemma Lahuerta has more than 25 years of experience in the pharmaceutical industry in the area of ​​Research and Development. Her professional career has focused on injectable drug development with an extensive track record of drugs successfully taken to the clinical phases and marketing...

Simona Rondini is the Head of Bacterial Vaccine Development and Senior Project leader at GSK Vaccines Institute for Global Health (GVGH) in Siena (Italy). Simona holds a PhD in Microbiology awarded by the Swiss Tropical Public Health Institute in Basel, and conducted postdoctoral studies at the...

Taylor has a Master’s in Public Health (MPH) from the University of North Texas Health Science Center and a B.S. from Texas A&M University. He is adjunct public health faculty at Texas A&M University and maintains his board certification by the National Board of Public Health Examiners. ...

Miriam Sturkenboom is head of the Department of Datascience and Biostatistics in the Julius Center at University Medical Center Utrecht in the Netherlands. She has a PhD from the Faculty of Mathematics and Physics in Groningen (cum laude), a pharmacy degree from the same University and a Master in...

Dr. Nicolas Burdin serves as Global Head of R&D at Clover. Dr. Burdin has spent over 27 years in vaccine research and development (R&D) with increasing responsibility roles at Sanofi, contributing to the successful progression of multiple prophylactic and therapeutic projects against...

Dr. Cooke is CEO of Omniose.  He has over thirty years of experience in the biopharmaceutical industry with a focus on vaccines.  He was previously CEO of NovaDigm Therapeutics, CEO of Mojave Therapeutics, COO at AVANT Immunotherapeutics, and SVP at Ology Bioservices. Prior to his leadership roles...

    Dr Niklas Blomberg joined IHI as Executive Director in January 2024. He brings to the role extensive experience in both research and leadership roles in the life sciences.   A Swedish national, he has a bachelor’s degree in chemistry from the University of Gothenburg, and a PhD in...

Dr. Luigi Buonaguro is the Director of the Innovative Immunological Models at the National Cancer Institute - IRCCS “Pascale ”, Naples – Italy. He is an expert in identification and characterization of tumor antigens for preventive/therapeutic cancer vaccine development. His focus is mostly on...

Jaime Espín has a PhD in Economics (University of Granada), a Bachelor Degree in Law (University of Granada) and a Master in Health Economics (Andalusian School of Public Health). He has been Visiting Graduate Fellow in the Department of Economics in the University of California (UCSB); Visiting...

Dr. Nicola Esposito is an accomplished scientist with over 15 years of experience in the field of molecular biology and vaccine development. As the QC Molecular Biology Assays Manager at ADVAXIA Biologics, Dr. Esposito leads a team responsible for new analytical method development and...

Chief scientific officer since 2019, responsible for the overall scientific company strategy. Heading a team of innovators taskes with pushing thte boundaries of cell-free protein espression accelerating biotherapeutic development. Biologist/Immunologist by training with over 25 years’ experience...

Dr Henao- Restrepo is a physician, communicable diseases epidemiologist and, clinical trialist. She leads the WHO’s R&D Blueprint for action to prevent epidemics.   The R&D Blueprint for epidemics was established at the World Health Assembly in May 2016. It is a global strategy and...

Emilie Karafillakis is an Assistant Professor and European Director of the Vaccine Confidence Project (VCP), with appointments at the London School of Hygiene and Tropical Medicine as well as at the University of Antwerp (European office of the VCP).She has around 10 years of experience as a social ...

Teresa Lambe is the Calleva Head of Vaccine Immunology and a Professor of Vaccinology & Immunology at the University of Oxford. She is leading a research group which improves human health by controlling disease through vaccination – stopping epidemics before they become pandemics. Prof Lambe is ...

Andreea Iordache joined Vaccines Europe in 2021 and currently holds the position of Manager Science & Regulatory Affairs. Vaccines Europe is a specialised subgroup within the European Federation of Pharmaceutical Industries and Associations. representing major innovative research-based vaccine...

Irene is the malaria programme manager at the European Vaccine Initiative (EVI). EVI is a leading European nonprofit Product Development Partnership (PDP), based in Heidelberg, Germany, that supports global efforts to develop effective and affordable vaccines against diseases of poverty and...

Sibilia Quilici joined Vaccines Europe as Executive Director in January 2021. Vaccines Europe  (VE) represents major innovative research-based vaccine companies operating in Europe, including small and medium-sized enterprises. Together with its direct membership of 14 leading vaccine companies and ...

Birgitte Rønø joined Evaxion in 2017 and was appointed Chief Science Officer in 2021. Dr. Rønø has more than 20 years' experience in biopharmaceutical drug discovery from academia and industry and received her PhD in experimental oncology and immunology from National Institutes of...

Avencia Sánchez-Mejías is CEO and co-Founder of Integra Therapeutics, a global leader in creating next generation gene writing tools to make advanced therapies safer and more effective. Avencia has experience in business management and transferring technology of excellence from academia to industry ...

Amy Shurtleff holds a Ph.D. in Viral Pathogenesis and is Head of Animal Models in the Laboratory Research and Innovations Department in the Division of Research and Development at the Coalition for Epidemic Preparedness Innovations (CEPI). Dr Shurtleff administers research programs for preclinical...

PhD in Cell Biology, Founder of Oxford Diagnostic Laboratories, UKAS- accredited Laboratory under ISO 17025:2017 serving National Health service UK and Public Health. With 18+years of industry experience in Laboratory Operations, Clinical Research and Medical Affairs. Thought leadership in...

Thomas is Director of Bioinformatics and AI/ML at Evaxion and is currently leading the development of Evaxion’s AI-Immunology™ platform for designing vaccines against cancer and infectious diseases. Prior to joining Evaxion in 2016, Thomas acquired his PhD in Immunological Bioinformatics from the...

Charlotte Vernhes is a bioengineer with 14 years of diversified experience in vaccine research and development. Since 2023, she leads Scientific and Medical Affairs at Vaccines Europe, a specialised vaccines group within the European Federation of Pharmaceutical Industries and Associations...

Dr. Evans is the Chief Scientific and Strategy Officer and Co-founder of Inimmune Corp. Dr. Evans is also Director of the Center for Translational Medicine at the University of Montana. He has over 20 years’ experience in the biotechnology and pharmaceutical industry including 15 years at...

 Holy Akwar is the Deputy Head of the Antimicrobial Resistance & Veterinary Products Department at the World Organization for Animal Health (WOAH) and also serves as the WOAH Liaison Officer to the Quadripartite Joint Secretariat (FAO, UNEP, WHO, & WOAH) for AMR. He possesses more than...

PhD in Molecular Biology, MSc Science Communication, MA Diplomacy and Foreign Affairs Director of Strategic Foresight and International Relations; President of the Council of European BioRegions (CEBR); Member of the Board of Directors of the European Clusters Alliance (ECA); Member of the Joint...

Cari Kessing has been serving as a Director in Vaccines Lab Operations at IQVIA Laboratories since 2022. Following her doctoral/postdoctoral training at Emory University, Vaccines and Gene Therapy Institute and Scripps Institute, she transitioned to the Vaccines industry at GSK, accruing extensive...

Swati Gupta, DrPH, MPH, leads IAVI’s Emerging Infectious Disease product portfolio and the development of the organization’s overall scientific strategy. She has a particular focus in leveraging IAVI’s recombinant vesicular stomatitis virus (rVSV) platform and expertise to expand product...

Kelli Aufderheide is a dynamic leader with more than 17 years at IQVIA Laboratories, currently serving as the Director of Decentralized Laboratory Solutions (DCT). Starting in Study Setup and moving through roles in Project Management, Project Setup, Line Management, and IT, Kelli's career...

George Simeon is the CEO of Curevo Vaccine. He joined Curevo at the beginning of 2019 and has over 30 years of experience in the healthcare sector working with multinational firms, start-ups, and not-for-profits. He has worked in biotech, pharmaceuticals, medical devices, IVD, and healthcare...

Prof. William Ampofo is a Virologist and has a keen interest in the management of viral infections, teaches graduate student courses and conducts research projects on viral diseases as an Associate Professor of Virology at the University of Ghana, College of Health Sciences, Noguchi Memorial...

Mr. Joffrey Benford oversees an impressive $1.7 billion in annual expenditures. As the Director of BARDA's Division of Contracts Management and Acquisitions (CMA), he manages a contract portfolio valued at over $72 billion, providing crucial executive advice and contracting management for all...

Professor Lucy Chappell is Chief Scientific Adviser to the Department of Health and Social Care and Chief Executive Officer of the National Institute for Health and Care Research (NIHR), the UK’s largest funder of health and care research. The Chief Scientific Adviser has overall responsibility for ...

Jack Evans has a diverse work experience spanning several companies in the research and clinical trials industry. Jack started their career at MAC Clinical Research as a Clinical Research Coordinator from November 2012 to June 2013. Jack then took on the role of Clinical Lead from June 2013 to...

Mr. Enrique Mañán, a distinguished Hubert Humphrey Service to America Award winner, serves as the Chief of Staff for the Division of Contract Management and Acquisitions (CMA) within the Center for Biomedical Advanced Research and Development Authority (BARDA). In this pivotal role, he ensures that ...

Dr. Martin Pech is a biosystems engineer by training. He gains his first experience in the industry at Roche Diagnositics in Penzberg, Germany, in a CTM department and stayed there for two years. He has worked five years as scientist at the University of Lübeck, Germany and Sydney Australia, to...

Martin Rabel, Dipl.-Pharm., Ph.D. currently works as a Global Sales Specialist | Biopharma Services for Cytiva supporting clients in Europe, Middle East, and Africa (EMEA) and Asia & Pacific (APAC). He obtained his pharmaceutical license as well as a postgraduate diploma from the...

Dr. Volker Sandig initiated ProBioGen’s cell line development program in 2000 resulting in the unique CHO.RiGHT® platform for protein production. He is co-inventor of key ProBioGen technologies including AGE1 designer cell lines, GlymaxX® and DirectedLuck®. His current work aims at modernizing...

Dr. Aleksandra E. Sikora is a Professor in the College of Pharmacy at Oregon State University (OSU) and Adjunct Professor in the Vaccine and Gene Therapy Institute at Oregon Health & Science University (OHSU).Dr. Sikora is a microbiologist with experiences in vaccine design, reverse...

​​​​​​Jane True is Vice President for mRNA Commercial Strategy and Innovation and Global Pandemic Security Lead at Pfizer, directing a team responsible for mRNA platform, pipeline, and product strategy. True also leads the charge on preparing the global community for future pandemics and achieving...

Mario Barro is the CEO of GIVAX, a vaccine development startup dedicated to eliminating the burden of preventable GI tract infections in children and adults. As the CEO, Mario is leading the development of innovative vaccine solutions designed to address critical unmet medical needs. In addition to ...

urrently serving as the Chief Scientific Officer (CSO) of NEC Oncoimmunity, Kaidre Bendjama oversees all oncology and infectious disease projects within the NEC Bio group. Kaidre is a seasoned translational scientist specializing in the development of vaccines for cancer and infectious...

Robert Choy, PhD is Director, Research and Development in PATH’s Center for Vaccine Innovation and Access. PATH is a nonprofit global health organization dedicated to advancing simple, affordable, and accessible technologies to increase health equity in low-income countries. Robert serves as a...

Jonathan Heeney is CSO and founder of DIOSynVax; “Digitally Immune Optimised Synthetic Vaccines”, a clinical stage Biotech based in Cambridge UK. DIOSynVax’s Computational Vaccine antigen technology leverages AI to design broadly protective vaccine antigen payloads to protect from high consequence...

Nektaria Karavas is the Global Director of Business Development for Nasal Vaccines, Antivirals and Immuno-stimulants at Aptar Pharma. Ms. Karavas joined Aptar Pharma in 2004 and has held various commercial roles executing long-term strategy within key customer and global accounts in North America...

Dr. Dave Liebowitz has over 27 years of industry experience in clinical and preclinical development in Oncology, Infectious Diseases (Virology), Vascular Biology, Inflammation and Metabolic Disorders with protein, small molecule, cellular therapeutic, and vaccine modalities. He was previously...

  Name : Kilian Mullett Position : Senior Director , Commercial Supply strategy Organisation / Company : Pfizer Biotech Address :  Grange Castle International Business Park , Clondalkin, Dublin , 22 , Country : Ireland Email:  Kilian.Mullett@pfizer.com Phone : +353-1-4696832   Kilian is a...

Tyler Sandberg is a scientist holding a PhD in vaccine immunology from the Karolinska Institute and a master’s degree in immunology and infection biology from Uppsala University. His doctoral research involved conducting several vaccine studies to examine human immune responses to various...

Lucas Silva is a Molecular and Cellular Biologist by academic training from the University of Lisbon and currently is working as a Senior Specialist leading the Analytical services at Nanopharm, an Aptar Pharma company.Prior to his experience in Nanopharm, Lucas did a research internship at...

Miriam Taegtmeyer is a Professor of Global Health at the Liverpool School of Tropical Medicine, where she heads the Community Health Systems Research Group.  The group consists of staff and doctoral students with a research portfolio of over £8 million (2018), spanning 11 countries across Africa...

Professor Andrew Ustianowski is a Consultant Physician in Infectious Diseases at the Regional Infection Unit, North Manchester General Hospital, UK, and the interim Executive Director for the National Institute of Health Research (NIHR) - Research Delivery Network (RDN). Previously he has been...

Cesar is part of Regulatory Innovation & Global Engagement and serves as International Policy Lead at Accumulus Synergy.  In his role, he collaborates with industry experts, national regulators, and global organizations to support policy updates and develop strategies that enhance regulatory...

Xinhao Ye has 15 years of vaccine development experience with growing responsibilities in research, development, and commercialization of different types of vaccines, including polysaccharide conjugate vaccines, recombinant protein, and mRNA-based vaccines. Before joining WuXi Vaccines, he worked...

Monika Ballmann graduated from Eötvös Loránd University of Sciences in Budapest, Hungary, specializing in Molecular and Microbiology. She earned her PhD in Veterinary Virology in 2017 from the University of Veterinary Medicine, Budapest. During her studies, she received a prestigious Marie Curie...

Sumi Biswas is a distinguished immunologist with a specialized focus on the development of vaccines against malaria, particularly those aimed at blocking the sexual development of the malaria parasite in the mosquito vector to prevent transmission. Her research encompasses all stages of vaccine...

Dr. David Burkhart is the Chief Operating Officer and Co-Founder of Inimmune, while also overseeing the formulation science R&D team. Dr. Burkhart was an investigator with GlaxoSmithKline for nearly 8 years leading the formulation R&D team where he demonstrated a knack for innovation and...

Stefaan De Koker holds a master in Bio-engineering and obtained his PhD at the lab for Molecular Immunology at Ghent University. Throughout his career, Stefaan has had a keen interest in understanding how activation of the innate immune system shapes the adaptive immune system and in translating...

Dr. Jae Myun Lee is the Professor and Chair of the Department of Microbiology & Immunology at Yonsei University College of Medicine. Dr. Lee is also a Scientific Advisor for QuadMedicine Inc., where his expertise plays a crucial role in driving technological advancements and innovative research ...

Don has 20 years of experience in the pharma and medical device industry. Don joined SPI Pharma in January 2020 as Global Business Development Manager. Before joining SPI Pharma, Don worked for Celanese as their Global Business Director. Prior to this, Don led business development for the...

Dr. Zeil Rosenberg is responsible for vaccine development at Tonix Pharmaceuticals. Previous to this, he was Therapeutic Area Head for Vaccines at PPD (AES) , Worldwide Business Leader for Vaccines at Becton Dickinson (BD), and resident National Immunization Advisor in Indonesia through USAID and...

Vic Suarez, Colonel (Ret), US Army, MS, PMP, CMRP is the Founder and Principal Growth Partner of Blu Zone Bioscience & Supply Chain Solutions, LLC. Blu Zone Bio assists biotechnology and life science supply chain organizations accelerate growth and expand domestic biomanufacturing through...

I am a clinician scientist studying viral disease and vaccines, particularly arboviruses. I am based in Liverpool where I perform early phase human trials and human experimental medicine studies looking at immune responses to viruses and viral vaccines in detail. My areas of technical...

Arno van der Ark is working for more than 35 years in vaccine development, ranging from developing alternatives to animal testing, removing of animal derived raw materials in vaccine production processes, developing a safe and effective intranasal pertussis OMV vaccine and lately managing the...

Heather Zar is Professor & Head of the Department of Paediatrics and Child Health and Director of the School of Child and Adolescent Health at the University of Cape Town (UCT), South Africa.  After specialising in paediatrics she did 3 years of sub-specialist training in paediatric pulmonology ...

Chase is the CEO and co-founder of Enepret Inc. He earned his doctorate degree at the University of Kentucky studying and engineering the biosynthesis of triterpene oils, like squalene. After advancing a yeast system to produce triterpene oils developed in his adviser's (Dr. Joe Chappell)...

Maria is the Director of the Vaccine Innovation Pathway at the National Institute for Health and Care Research (NIHR), bringing over 20 years of experience in driving strategy and innovation in health and life sciences research services. She has extensive experience collaborating with a wide range...

Suzanne Welten, PhD  Scientific Manager Immunology (Bacterial Vaccines) Johnson & Johnson The Netherlands Suzanne Welten, Ph.D. is a Scientific Manager Immunology working on bacterial vaccines within JNJ Innovative Medicine (Janssen Vaccines & Prevention B.V.) in Leiden, the...

Marta is a Regulatory Affairs CMC Director, at Merck Sharp & Dohme based in London. She has demonstrated experience in Regulatory Affairs and Quality Assurance areas in global pharmaceutical companies. She is specialized in pre and post-approval CMC regulatory strategies in EU and EMEA markets...

Javier Cid, MD, DrPH, MBA, MSc, is a Senior Research Scientist in the RWE group at Evidera, part of the PPD clinical research business of Thermo Fisher Scientific, in Barcelona, Spain.  Dr. Cid is a healthcare professional with more than 20 years of experience, 11 of which were spent working for...

Wayland Coker currently serves as the Chief Supply Chain Strategist, Supply Chain Optimization Office Director, in the Industrial Base Management & Supply Chain (IBMSC) program office at the Administration for Strategic Preparedness and Response (ASPR). He is a retired Naval Officer, serving...

Bernard Fritzell, MD has been an independent consultant in vaccinology and vaccine development at BFL conseils SAS since 2012. Current member of TBVI clinical development team, the IABS human vaccine group and the SPEAC’s Meta-DSMB for CEPI funded projects, former member of the French Scientific...

She has a degree in Pharmaceutical Sciences and graduated in 1998 from the Central University of Las Villas. She completed her doctoral training in immunopharmacological issues, obtaining in 2006 the degree of Dr. in Pharmaceutical Sciences. She has been a Principal Investigator since 2015. She...

Founder of VaxTRIALS. More than 15 years of experience in differents positions, including Site, CRO and Sponsor roles in the vaccine clinical trials industry in Latin America; with more than 70.000 subject managed in vaccine clinical trials.

Ms. Arlene Joyner is the Director of the Industrial Base Management and Supply Chain for the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). In this role, she is responsible for leading HHS efforts on Advanced...

Dr.Alessandro Manenti obtained the Ph.D degree in Biotecnologies of Vaccines at the University of Siena in 2016. After several years as Project Director following the testing of Phase I,II and III  clinical trials, he joined the position of Chief Development officer in VisMederi, a medium...

Narcisa Mesaros, MD, is the Vice President of the Medical Science & Strategy group at PPD, the clinical research business of Thermo Fisher Scientific. She joined PPD from Janssen where she worked as the Clinical Franchise Leader for bacterial vaccines portfolio. Prior, Narcisa spent 15 years...

Sarah Rosen, MSc, is a Senior Director within the RWE group at Evidera, part of the PPD clinical research business of Thermo Fisher Scientific, in France. Ms. Rosen has been working in non-interventional studies for nearly 20 years, initially as a Project Manager and Oversight Director, and now...

Claire Sears is the Head of Business Transformation at EMS Healthcare, driving strategic initiatives to enhance healthcare accessibility. With over 25 years in pharmaceutical research, clinical technology, and academia, she is a leader in clinical trial technology and site engagement. Claire’s...

Medical doctor, Priv. Doz. Dr med. Fully licensed otorhinolaryngologist, with 10 years of clinicial and research experience in oncology / solid tumors>10 years in pharmaceutical industry (Biontech SE, previously MSD Sharpe Dhome, CSL-Vifor), including Significant launch experience in oncology...

Dr. Elissa Weitzman, ScD, MSc, is an internationally recognized social and behavioral scientist who has made significant contributions to understanding and ameliorating problems related to adolescent substance use and chronic illness. She is an Associate Professor of Pediatrics at Harvard Medical...

Hamilton Bennett (she/her) is the Senior Director of Vaccine Access and Partnerships at Moderna, a company pioneering messenger RNA (mRNA) therapeutics and vaccines. In this role, Hamilton is responsible for the Global Public Health and Medical Countermeasures portfolio, driving collaborative...

Dr. Brander has been studying cellular immunity to different viral infections, including HIV, HCV and tumorigenic human herpesviruses, such as EBV and KSHV.  He has published more than 250 peer-reviewed articles, many focusing on properties  of viral-epitope specific T cells and how T cell receptor ...

Denis R. Cavert is CEO and co-founder of Vaxxel, a Biotech start-up developing intranasal respiratory vaccines against bronchiolitis and viral pneumonia. Vaxxel was created in 2019 with the University of Lyon, France and with the University of Laval, Canada. In vivo Proof of Concept of the first...

Dr Rosaria Esposito is a Field Scientist at bioMérieux. She provides application and scientific support to VaxArray® users in Europe. The VaxArray® platform is developed and commercialized by the company InDevR (Boulder, CO), for which bioMérieux is the exclusive distributor in Europe. Dr Esposito...

Eric Fevre is a joint appointee at the International Livestock Research Institute (ILRI) and Professor of Veterinary Infectious Diseases at the Institute of Infection, Veterinary and Ecological Sciences (IVES), University of Liverpool.  He manages several field-orientated projects focussed on...

I am a virologist interested in vaccine design and preclinical development of mRNA-lipid nanoparticle-based technologies. I have worked on two products that are currently in clinical trials: mRNA-1769 for use in preventing Orthopoxvirus infection and mRNA-1608 for therapeutic treatment of Herpes...

Dr. Holger is the Co-founder and Chief Scientific Officer of Omniscope. He also leads the Single Cell Genomics Group at the Spanish National Centre for Genomic Analysis (one of Europe’s largest Genome Centres). He has co-authored over 80 publications, and his research has received over €7.5m...

Dr. Huebner has over 30 years of experience in biologics development with a large focus on vaccines while working in large pharma companies, government agencies, and contract research organizations. At LBG, Dr. Huebner supports both commercial and U.S. Government-funded programs as a subject matter ...

Karin Jooss, Ph.D., has served as our Executive Vice President and Head of Research and Development since March 2021. Previously, since April 2016, Dr. Jooss had served as our Executive Vice President of Research and Chief Scientific Officer. Prior to Gritstone, from May 2009 to April...

Randy Lacey, PhD, completed his bachelor’s degree in biology and chemistry at Austin Peay State University prior to completing his doctoral studies in biochemistry and molecular biology at the University of Tennessee. Following his PhD studies, Randy worked as a postdoctoral research fellow first...

I qualified in Medicine from the University of Oxford in 1980.  After working around the UK in hospital medicine and research, I joined the pharmaceutical industry in 1986.  I am a Fellow of the Faculty of Pharmaceutical Medicine and a Fellow of the Academy of Medical Sciences. For over 30 years I...

Dr. Gerben Marsman obtained his doctorate degree at Sanquin Research (Amsterdam, The Netherlands) and completed a post-doctoral research position at the Max-Planck Institute for Infection Biology (Berlin, Germany). He joined the VFI in 2023 as a Project Manager and is currently Head of Alliance...

​​​​​​Dr. Romain Micol has been President, co-founder, and Chief Executive Officer of Combined Therapeutics since 2016. Previously, he held several positions across the Institut Mérieux group: ABL Inc (USA), Shantha Biotechnics (India), and Transgene (China and France). Dr. Micol helped to set up...

Marta G. Murreddu is a seasoned professional in clinical research, virology, and project management. She successfully oversaw clinical trials, managed client communications, and ensured adherence to timelines and budgets. From 2021 to 2023, she led Clinical Virology Services at Viroclinics, where...

My research focuses on induction of protection immunity, typically focusing on mucosal immunity, infection, and adjuvants. My lab uses bacterial ADP-ribosylating enterotoxins derived from E. coli for the manipulation of protective immunity, including the novel adjuvants dmLT and LTA1. In...

Technical Director of Health Supply Chain, Giovanna has over 20 years of experience in leading the design and implementation of robust end-to-end supply chain solutions worldwide. With a strong operational background in Pharma and Life Sciences distribution systems working at DHL, Giovanna has...

Meta Roestenberg is an infectious diseases clinician at Leiden University Medical Center in the Netherlands  where she leads a group of translational researchers in answering key questions related to host-pathogen interaction by making use of controlled human infection models. Her team pioneered...

Kristyna works as an Applications Scientist for Imaging and BioPharma at Molecular Devices. She has a strong background in Cellular and Molecular Biology, and, in her role, she focuses on 2D & 3D Cell Culture, Cell Line Development, and Automation. Before joining Molecular Devices, she earned...

Dr. Nitin M. Shetty is the CTO and Deputy Test Facility Manager at Bioneeds, a preclinical CRO in India recognized for its OECD GLP certification and USFDA audits. With over 30 years of industry experience, he specializes in the preclinical development of vaccines, biopharmaceuticals, and medical...

PJ Kim’s 20+ years in regulated pharmaceuticals, healthcare, and clinical trials includes responsibilities in quality, sales, program management, key account management, and corporate strategy. At ApiJect, Mr. Kim is responsible for developing strategic plans for new and existing key accounts in...